We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Tests for POC and Homeland Defense

By HospiMedica staff writers
Posted on 10 Dec 2003
Exclusive rights to market an innovative line of rapid-result blood and urine tests have been granted to QT 5, Inc. More...
(Westlake Village, CA, USA; www.qt5inc.com) by an undisclosed source. The diagnostic platform was specifically designed for point-of-care (POC) and ambulatory use as well as for the emerging homeland defense market.

The patented test platform incorporates a combination of a solid phase membrane and immunologic-based reagents in a single-use disposable test device. The platform has the capacity for providing rapid POC testing for a wide variety of medical conditions. The diagnostic platform is highly flexible and capable of testing for important infectious diseases, drugs, and drug metabolites. Depending upon the application, this platform technology may provide either quantitative or qualitative test results in minutes with a high degree of accuracy.

QT 5 will include in its initial product offering a low-cost, small-footprint desktop analyzer designed for use with the rapid test cartridges. A handheld mobile version of the multiple assay analyzer will be compatible with a wide variety of new tests being developed for use by paramedics, assisted-living facilities, and military groups. QT 5 has developed another line of qualitative fast tests for rubella, herpes virus, rotavirus, strep group A, and infectious mononucleosis that have been cleared by the U.S. Food and Drug Administration (FDA).




Related Links:
QT 5

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Drug Testing Assays
Atellica DT 250 Analyzer
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.